These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1155490)

  • 21. Clinical pharmacology of tobramycin in infants.
    Bratlid D; Fuglesang JE
    Scand J Infect Dis; 1979; 11(1):73-6. PubMed ID: 419372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of children for whom routine monitoring of aminoglycoside serum concentrations is not cost effective.
    Massey KL; Hendeles L; Neims A
    J Pediatr; 1986 Nov; 109(5):897-901. PubMed ID: 3095524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminoglycoside pharmacokinetic parameters in neurocritical care patients undergoing induced hypothermia.
    Mercer JM; Neyens RR
    Pharmacotherapy; 2010 Jul; 30(7):654-60. PubMed ID: 20575630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of impairment of renal function and dialysis on the serum and urine levels of clindamycin.
    Peddie BA; Dann E; Bailey RR
    Aust N Z J Med; 1975 Jun; 5(3):198-202. PubMed ID: 1057932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Administration of tobramycin in the beginning of the hemodialysis session: a novel intradialytic dosing regimen.
    Kamel Mohamed OH; Wahba IM; Watnick S; Earle SB; Bennett WM; Ayres JW; Munar MY
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):694-9. PubMed ID: 17699484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.
    Coulthard KP; Peckham DG; Conway SP; Smith CA; Bell J; Turnidge J
    J Cyst Fibros; 2007 Apr; 6(2):125-30. PubMed ID: 16829216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose tobramycin combined with clindamycin or lincomycin in the treatment of septic peritonitis and intraabdominal sepsis.
    Muth L; Edén T
    Acta Chir Scand; 1981; 147(5):339-46. PubMed ID: 7324760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timing of inhaled tobramycin affects assessment of intravenous tobramycin pharmacokinetic monitoring.
    Stenbit AE; Bullington WM; Heh JL; Flume PA
    J Cyst Fibros; 2013 Jul; 12(4):403-6. PubMed ID: 23266092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tobramycin in patients with various infections: a clinical evaluation.
    Atterholm I; Hedström SA; Kahlmeter G; Kamme C
    Scand J Infect Dis; 1978; 10(3):229-34. PubMed ID: 362517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with tobramycin in the treatment of infections due to gram-negative bacilli.
    Carmalt ED; Cortez LM; Rosenblatt JE
    Am J Med Sci; 1976; 271(3):285-95. PubMed ID: 820195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ototoxicity of tobramycin in humans - influence of renal impairment.
    Brogard JM; Conraux C; Collard M; Lavillaureix J
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):408-16. PubMed ID: 6982875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid intravenous injection of tobramycin: suggested dosage schedule and concentrations in serum.
    Gillett AP; Falk RH; Andrews J; Wise R; Melikian V
    J Infect Dis; 1976 Aug; 134 Suppl():S110-3. PubMed ID: 985661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tobramycin in the medical intensive care unit.
    Ellinoy BR; Matsuda K; Nguyen TM
    Crit Care Med; 2005 Apr; 33(4):919. PubMed ID: 15818142
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjustment of cephaloridine (Keflodin): dosage according to its pharmacokinetics.
    Brogard JM; Brandt C; Dorner M; Dammron A
    Chemotherapy; 1976; 22(1):1-11. PubMed ID: 1253626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbenicillin inactivation of aminoglycosides in patients with severe renal failure.
    Weibert R; Keane W; Shapiro F
    Trans Am Soc Artif Intern Organs; 1976; 22():439-43. PubMed ID: 951863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of tobramycin and gentamicin by the intravenous route every 6 hr in patients with normal renal function.
    Setia U; Gross PA
    J Infect Dis; 1976 Aug; 134 Suppl():S125-9. PubMed ID: 972270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients.
    Jacobson PA; West NJ; Price J; Hutchinson RJ
    Ann Pharmacother; 1997 Oct; 31(10):1127-31. PubMed ID: 9337435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis.
    Bates RD; Nahata MC; Jones JW; McCoy K; Young G; Cox S; Barson WJ
    Chest; 1997 Nov; 112(5):1208-13. PubMed ID: 9367459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tobramycin pharmacokinetics in morbidly obese patients.
    Blouin RA; Mann HJ; Griffen WO; Bauer LA; Record KE
    Clin Pharmacol Ther; 1979 Oct; 26(4):508-12. PubMed ID: 487698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
    de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
    Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.